DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Quess Corp Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·8 Oct 2026, 8:43 am

Quess Corp

Quess Corp Limited has informed stock exchanges that it has received a certificate under SEBI's (Depositories and Participants) Regulations, 2018. This regulatory requirement is mandatory for entities that act as Depository Participants, which involves facilitating dematerialization and settlement of securities.

For investors, this development is a procedural milestone. It confirms that Quess Corp has met the necessary compliance standards to operate as a Depository Participant. Meeting such regulatory obligations is a standard part of corporate governance and ensures the company's continued eligibility to function in the securities market.

Investors should monitor the company's future announcements for any updates on its depository services. While this news itself is largely procedural, it reinforces the company's adherence to regulatory frameworks, which is a positive signal for maintaining market credibility.